Capriati blasts Sharapova after dope test revelation

Image
AFP Los Angeles
Last Updated : Mar 08 2016 | 6:03 PM IST
Former Grand Slam champion Jennifer Capriati lashed out at Maria Sharapova on Twitter Monday after the Russian announced she had tested positive for a banned drug at the Australian Open in January.
In a series of tweets that didn't mention Sharapova by name, Capriati said she was "disappointed."
"I had to lose my career and never opted to cheat no matter what," Capriati tweeted. "I had to throw in the towel and suffer.
"I didn't have the high priced team of (doctors) that found a way for me to cheat and get around the system and wait for science to catch up."
During a quickly convened news conference at a Los Angeles hotel on Monday, Sharapova said she tested positive for Meldonium, a circulation-boosting drug used to treat heart ailments that was added to the World Anti-Doping Agency's banned list this year.
Sharapova said she had been taking the drug for health problems on medical advice since 2006, and through her own negligence failed to realize it had been banned.
"What's the point of someone taking a heart medicine that helps your heart recover faster unless you have a heart condition? Is that accurate," Capriati said.
"In my opinion (if) it's all true every title should be stripped. This is other people's lives as well."
At her induction into the Tennis Hall of Fame in 2012, Capriati said she felt injuries had forced her to leave the game sooner than she wanted.
She launched her career at 14, but after winning Olympic gold at Barcelona in 1992 she was sidetracked by off-court troubles, including arrests for shoplifting and marijuana possession.
She returned to tennis in 1996 and won the first of her three Grand Slams at the Australian Open in 2001, adding the French Open title and another Australian crown before she retired in 2004.
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Mar 08 2016 | 6:03 PM IST

Next Story